BioPharma Dive17m
Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.
FDA Approves New Painkiller That Shows Promise and Challenges of Opioid Alternatives
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
FDA approves Ozempic to help reduce risk of worsening chronic kidney disease
The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...
CNN33m
FDA approves first new type of pain medication in 25 years
The US Food and Drug Administration signed off Thursday on the first new type ... another treatment option,” Dr. Jacqueline Corrigan-Curay, acting director of the FDA’s Center for Drug Evaluation and ...
FDA approves Vertex’s non-opioid painkiller, first new kind of pain medicine in decades
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...
Hosted on MSN42m
Costco's Recall On This Fan-Favorite Item Has Just Been Updated to Be 'Deadly'—Here's What to Know
Such is the case now for fans of the Kirkland Signature Smoked Salmon, a product that was first recalled last October and now ...
Yes, there is a Lay’s potato chip recall
A December recall on Lay’s Potato Chips sold in two states has been escalated to the FDA’s highest risk level, but no ...